Cargando…

Retrospective Study on the Application of Enhanced Recovery After Surgery Measures to Promote Postoperative Rehabilitation in 50 Patients With Brain Tumor Undergoing Craniotomy

OBJECTIVE: To investigate whether enhanced recovery after surgery (ERAS) can promote rehabilitation of patients after neurosurgical craniotomy. METHODS: The clinical data of 100 patients with brain tumor undergoing craniotomy in the Department of Neurosurgery, Xiangya Hospital, Central South Univers...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, SongShan, Xie, Bo, Li, ZhenYan, Zhou, XiaoXi, Cheng, Quan, Liu, ZhiXiong, Tao, ZiRong, Zhang, MingYu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633504/
https://www.ncbi.nlm.nih.gov/pubmed/34868964
http://dx.doi.org/10.3389/fonc.2021.755378
_version_ 1784607941730500608
author Feng, SongShan
Xie, Bo
Li, ZhenYan
Zhou, XiaoXi
Cheng, Quan
Liu, ZhiXiong
Tao, ZiRong
Zhang, MingYu
author_facet Feng, SongShan
Xie, Bo
Li, ZhenYan
Zhou, XiaoXi
Cheng, Quan
Liu, ZhiXiong
Tao, ZiRong
Zhang, MingYu
author_sort Feng, SongShan
collection PubMed
description OBJECTIVE: To investigate whether enhanced recovery after surgery (ERAS) can promote rehabilitation of patients after neurosurgical craniotomy. METHODS: The clinical data of 100 patients with brain tumor undergoing craniotomy in the Department of Neurosurgery, Xiangya Hospital, Central South University, from January 2018 to August 2020 were collected, including 50 patients in the ERAS group and 50 patients in the control group. t-Test, Wilcoxon’s rank sum test, and chi-square analysis were used to compare the clinical characteristics, prognosis, and hospitalization time between the two groups. RESULTS: There was no significant difference in gender, age, and other general clinical data between the two groups (p > 0.05). The days of antiemetic drugs applied in the ERAS group were less than those in the control group (1.00 vs. 2.00 days, p = 0.003), and the proportion of patients requiring analgesics was lower than that of the control group (30% vs. 52%, OR = 0.41, 95% CI 0.18–0.93, p = 0.031). The time of urinary catheter removal and that of patients starting ambulation in the ERAS group were shorter than those in the control group (16.00 vs. 24.00 h, and 1.00 vs. 2.00 days, p < 0.001, respectively); and the hospital length of stay (LOS) in the ERAS group was shorter than that in the control group (Total LOS, 13.00 vs. 15.50 days; Postoperative LOS, 7.00 vs. 10.00 days, p < 0.001). By analyzing the prognosis of patients in the ERAS group and control group, we found that there was no significant difference in postoperative complications and Karnofsky Performance Status (KPS) score 1 month after operation between the two groups. CONCLUSION: The application of ERAS in craniotomy can accelerate the postoperative recovery of patients without increasing the perioperative risk, which is worthy of wide application. However, whether the ERAS measures can reduce the postoperative complications and improve the prognosis of patients still needs more large-scale case validation and multicenter collaborative study.
format Online
Article
Text
id pubmed-8633504
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86335042021-12-02 Retrospective Study on the Application of Enhanced Recovery After Surgery Measures to Promote Postoperative Rehabilitation in 50 Patients With Brain Tumor Undergoing Craniotomy Feng, SongShan Xie, Bo Li, ZhenYan Zhou, XiaoXi Cheng, Quan Liu, ZhiXiong Tao, ZiRong Zhang, MingYu Front Oncol Oncology OBJECTIVE: To investigate whether enhanced recovery after surgery (ERAS) can promote rehabilitation of patients after neurosurgical craniotomy. METHODS: The clinical data of 100 patients with brain tumor undergoing craniotomy in the Department of Neurosurgery, Xiangya Hospital, Central South University, from January 2018 to August 2020 were collected, including 50 patients in the ERAS group and 50 patients in the control group. t-Test, Wilcoxon’s rank sum test, and chi-square analysis were used to compare the clinical characteristics, prognosis, and hospitalization time between the two groups. RESULTS: There was no significant difference in gender, age, and other general clinical data between the two groups (p > 0.05). The days of antiemetic drugs applied in the ERAS group were less than those in the control group (1.00 vs. 2.00 days, p = 0.003), and the proportion of patients requiring analgesics was lower than that of the control group (30% vs. 52%, OR = 0.41, 95% CI 0.18–0.93, p = 0.031). The time of urinary catheter removal and that of patients starting ambulation in the ERAS group were shorter than those in the control group (16.00 vs. 24.00 h, and 1.00 vs. 2.00 days, p < 0.001, respectively); and the hospital length of stay (LOS) in the ERAS group was shorter than that in the control group (Total LOS, 13.00 vs. 15.50 days; Postoperative LOS, 7.00 vs. 10.00 days, p < 0.001). By analyzing the prognosis of patients in the ERAS group and control group, we found that there was no significant difference in postoperative complications and Karnofsky Performance Status (KPS) score 1 month after operation between the two groups. CONCLUSION: The application of ERAS in craniotomy can accelerate the postoperative recovery of patients without increasing the perioperative risk, which is worthy of wide application. However, whether the ERAS measures can reduce the postoperative complications and improve the prognosis of patients still needs more large-scale case validation and multicenter collaborative study. Frontiers Media S.A. 2021-11-12 /pmc/articles/PMC8633504/ /pubmed/34868964 http://dx.doi.org/10.3389/fonc.2021.755378 Text en Copyright © 2021 Feng, Xie, Li, Zhou, Cheng, Liu, Tao and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Feng, SongShan
Xie, Bo
Li, ZhenYan
Zhou, XiaoXi
Cheng, Quan
Liu, ZhiXiong
Tao, ZiRong
Zhang, MingYu
Retrospective Study on the Application of Enhanced Recovery After Surgery Measures to Promote Postoperative Rehabilitation in 50 Patients With Brain Tumor Undergoing Craniotomy
title Retrospective Study on the Application of Enhanced Recovery After Surgery Measures to Promote Postoperative Rehabilitation in 50 Patients With Brain Tumor Undergoing Craniotomy
title_full Retrospective Study on the Application of Enhanced Recovery After Surgery Measures to Promote Postoperative Rehabilitation in 50 Patients With Brain Tumor Undergoing Craniotomy
title_fullStr Retrospective Study on the Application of Enhanced Recovery After Surgery Measures to Promote Postoperative Rehabilitation in 50 Patients With Brain Tumor Undergoing Craniotomy
title_full_unstemmed Retrospective Study on the Application of Enhanced Recovery After Surgery Measures to Promote Postoperative Rehabilitation in 50 Patients With Brain Tumor Undergoing Craniotomy
title_short Retrospective Study on the Application of Enhanced Recovery After Surgery Measures to Promote Postoperative Rehabilitation in 50 Patients With Brain Tumor Undergoing Craniotomy
title_sort retrospective study on the application of enhanced recovery after surgery measures to promote postoperative rehabilitation in 50 patients with brain tumor undergoing craniotomy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633504/
https://www.ncbi.nlm.nih.gov/pubmed/34868964
http://dx.doi.org/10.3389/fonc.2021.755378
work_keys_str_mv AT fengsongshan retrospectivestudyontheapplicationofenhancedrecoveryaftersurgerymeasurestopromotepostoperativerehabilitationin50patientswithbraintumorundergoingcraniotomy
AT xiebo retrospectivestudyontheapplicationofenhancedrecoveryaftersurgerymeasurestopromotepostoperativerehabilitationin50patientswithbraintumorundergoingcraniotomy
AT lizhenyan retrospectivestudyontheapplicationofenhancedrecoveryaftersurgerymeasurestopromotepostoperativerehabilitationin50patientswithbraintumorundergoingcraniotomy
AT zhouxiaoxi retrospectivestudyontheapplicationofenhancedrecoveryaftersurgerymeasurestopromotepostoperativerehabilitationin50patientswithbraintumorundergoingcraniotomy
AT chengquan retrospectivestudyontheapplicationofenhancedrecoveryaftersurgerymeasurestopromotepostoperativerehabilitationin50patientswithbraintumorundergoingcraniotomy
AT liuzhixiong retrospectivestudyontheapplicationofenhancedrecoveryaftersurgerymeasurestopromotepostoperativerehabilitationin50patientswithbraintumorundergoingcraniotomy
AT taozirong retrospectivestudyontheapplicationofenhancedrecoveryaftersurgerymeasurestopromotepostoperativerehabilitationin50patientswithbraintumorundergoingcraniotomy
AT zhangmingyu retrospectivestudyontheapplicationofenhancedrecoveryaftersurgerymeasurestopromotepostoperativerehabilitationin50patientswithbraintumorundergoingcraniotomy